Table 1 Features of PCOS patients and non-PCOS patients undergoing their first IVF/ICSI cycles.

From: Analyses of optimal body mass index for infertile patients with either polycystic or non-polycystic ovary syndrome during assisted reproductive treatment in China

Parameter

n = 28523 (non-PCOS)

n = 2632 (PCOS)

P

Age (year)

32.56 ± 7.71

30.27 ± 4.92

0.000

BMI (kg/m2)

22.72 ± 3.12

23.60 ± 3.50

0.029

Infertile duration (year)

4.20 ± 3.43

4.03 ± 2.70

0.000

Basal FSH (IU/L)

8.08 ± 2.01

6.16 ± 1.49

0.189

Basal LH (IU/L)

6.18 ± 6.17

9.22 ± 7.60

0.000

Basal T (ng/ml)

0.82 ± 4.93

1.24 ± 6.82

0.002

IVF

19163

1596

 

ICSI

9030

934

 

primary infertility

17193 (60.28%)

2097 (79.67%)

0.000

secondary infertility

11330 (39.72%)

535 (20.33%)

0.000

Gn (days)

9.40 ± 6.34

10.07 ± 8.33

0.000

Gn dosage (IU)

1844.9 ± 1203.13

899.6 ± 903.45

0.000

No. of retrieved oocytes

10.75 ± 5.76

14.11 ± 5.93

0.000

No. of available embryos

5.41 ± 3.33

7.21 ± 4.41

0.000

No. of transferred embryos

2.06 ± 0.59

2.06 ± 0.59

0.908

Clinical pregnancy rate (%)

45.30% (12920/28523)

47.87% (1260/2632)

0.011

Abortion rate (%)

7.29% (1160/15921)

6.83% (93/1361)

0.536

Ectopic pregnancy rate (%)

2.09% (332/15921)

2.79% (38/1361)

0.084

  1. Notes: PCOS: polycystic ovary syndrome; non-PCOS: non-polycystic ovary syndrome; IVF: in vitro fertilization; ICSI: intracytoplasmic sperm injection; BMI: body mass index; FSH: follicular stimulation hormone; LH: luteinizing hormone; T: testosterone; Gn: gonadotropin.